Offer - Urjas Oil for just ₹ 1 X
Telista Trio CL 6.25 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Telista Trio CL 6.25 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Telista Trio CL 6.25 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Telista Trio CL 6.25 Tablet include Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Telista Trio CL 6.25 Tablet as well, which are listed below. Usually, these side effects of Telista Trio CL 6.25 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Telista Trio CL 6.25 Tablet is Mild for pregnant women and Mild for women who are breastfeeding. It is important to know if Telista Trio CL 6.25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Telista Trio CL 6.25 Tablet related warnings section.
Individuals suffering from medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia must refrain from the use of Telista Trio CL 6.25 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Telista Trio CL 6.25 Tablet are listed in the contraindications section below.
Besides this, Telista Trio CL 6.25 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Telista Trio CL 6.25 Tablet is not safe while driving, and is not addiction.
Telista Trio CL 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Telista Trio CL 6.25 Tablet safe for pregnant women?
Telista Trio Cl rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Telista Trio CL 6.25 Tablet safe during breastfeeding?
Breastfeeding women can take Telista Trio Cl as it bears very minor side effects for them.
What is the effect of Telista Trio CL 6.25 Tablet on the Kidneys?
Telista Trio Cl has very mild side effects on the kidneys.
What is the effect of Telista Trio CL 6.25 Tablet on the Liver?
Telista Trio Cl is rarely harmful for the liver.
What is the effect of Telista Trio CL 6.25 Tablet on the Heart?
Telista Trio Cl has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Telista Trio CL 6.25 Tablet unless your doctor advises you to do so -
Is this Telista Trio CL 6.25 Tablet habit forming or addictive?
Telista Trio CL 6.25 Tablet is not addictive in nature.
Interaction between Food and Telista Trio CL 6.25 Tablet
Eating certain foods may increase the time it takes Telista Trio CL 6.25 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Telista Trio CL 6.25 Tablet
Consult your doctor before consuming alcohol while taking Telista Trio CL 6.25 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448